C. elegans select.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Developmental Sensitivity in Schistosoma mansoni to Puromycin To Establish Drug Selection of Transgenic Schistosomes.Antimicrobial agents and chemotherapy · 2018
   Article
2. New research tools for urogenital schistosomiasis.The Journal of infectious diseases · 2015
   Review
3. Pseudotyped murine leukemia virus for schistosome transgenesis: approaches, methods and perspectives.Transgenic research · 2014
   Article
4. An antibiotic selection marker for schistosome transgenesis.International journal for parasitology · 2012
   Article
5. Establishing transgenic schistosomes.PLoS neglected tropical diseases · 2011
   Article
6. Selectable genetic markers for nematode transgenesis.Cellular and molecular life sciences : CMLS · 2011
   Review

Corrections and comments

• Comment on
  Rapid selection of transgenic C. elegans using antibiotic resistance.2010
• Comment on
  An antibiotic selection marker for nematode transgenesis.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as